Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated Akt

Gustavo Ayala(The University of Texas Health Science Center), Dov Kadmon(Brigham and Women's Hospital)
Clinical Cancer Research
November 14, 2008
10.1158/1078-0432.ccr-08-0839
Cited by 29

Related Papers

COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis
|Nature|2012|181
Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer
|Clinical Cancer Research|2009|174
Relaxin Promotes Prostate Cancer Progression
|Clinical Cancer Research|2007|126
Influence of the neural microenvironment on prostate cancer
|The Prostate|2017|85
Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance
|The Prostate|2020|39